TORNTPHARM₹4,524.40-1.97%
56/100
0100 · strongest
good
Weights come from configuration, not from this page — each pillar links to the section below that explains it.
Income stmtHistory
Profitability
headline ratiosGrowth
compounded, from filed annual resultsSegment Results
₹ CrWorking Capital & Efficiency
days · ROCE %TORNTPHARM financial summary
For Mar 2026, Torrent Pharmaceuticals Ltd reported revenue of ₹10,712 crore, which grew 10.6% from the previous year. Net profit was ₹2,192 crore, which grew 16.1% year on year, on an operating margin of 38%. Earnings per share came in at ₹64.75. Annual results are available for 14 financial years, from Mar 2013 to Mar 2026.
| Revenue | ₹10,712 crore |
|---|---|
| Net profit | ₹2,192 crore |
| Operating margin | 38% |
| EPS | ₹64.75 |